IRIS Institutional Research Information System - OPENBS Open Archive UniBS

MAZZIOTTI, Gherardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.578
EU - Europa 1.438
AS - Asia 865
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 4
AF - Africa 3
SA - Sud America 3
Totale 5.898
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.566
CN - Cina 434
UA - Ucraina 415
PL - Polonia 348
DE - Germania 217
SG - Singapore 195
FI - Finlandia 127
HK - Hong Kong 116
IT - Italia 83
IE - Irlanda 63
GB - Regno Unito 62
FR - Francia 61
TR - Turchia 57
IN - India 31
CZ - Repubblica Ceca 16
RU - Federazione Russa 15
VN - Vietnam 12
CA - Canada 11
SE - Svezia 10
BE - Belgio 9
EU - Europa 7
ID - Indonesia 6
IR - Iran 6
AU - Australia 4
NL - Olanda 4
JP - Giappone 3
CH - Svizzera 2
ES - Italia 2
MA - Marocco 2
RO - Romania 2
BD - Bangladesh 1
BR - Brasile 1
CL - Cile 1
DK - Danimarca 1
EC - Ecuador 1
GE - Georgia 1
KR - Corea 1
MU - Mauritius 1
MX - Messico 1
PK - Pakistan 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 5.898
Salva come PNG Salva come JPEG
Città #
Fairfield 644
Warsaw 347
Houston 341
Ashburn 335
Woodbridge 316
Jacksonville 290
Seattle 246
Cambridge 234
Ann Arbor 215
Wilmington 198
Singapore 155
Chandler 124
Princeton 118
Hong Kong 116
Nanjing 103
Beijing 96
Helsinki 71
New York 69
Dublin 63
Istanbul 56
Nanchang 51
Des Moines 32
San Diego 30
Shenyang 30
Brescia 27
Shanghai 22
Jiaxing 20
Changsha 19
Hebei 16
Washington 16
Milan 15
Boardman 14
Brno 14
Tianjin 13
Dong Ket 12
Kunming 12
Mumbai 12
Hangzhou 11
Toronto 10
Augusta 9
Brussels 9
Munich 9
San Francisco 9
Los Angeles 8
San Mateo 8
Cassina de' Pecchi 7
London 7
Greifswald 6
Jakarta 6
Lancaster 6
Leawood 6
Jinan 5
Monmouth Junction 5
Ardabil 4
Dalmine 4
Dearborn 4
Haikou 4
Ningbo 4
Redwood City 4
Verona 4
Falls Church 3
Genoa 3
Lanzhou 3
Lappeenranta 3
New Bedfont 3
Nürnberg 3
Romola 3
Tokyo 3
Bangalore 2
Catania 2
Fuzhou 2
Kilburn 2
Napoli 2
Olomouc 2
Phoenix 2
Rabat 2
Taizhou 2
Zhengzhou 2
Almere Stad 1
Ambrolauri 1
Bratislava 1
Bucharest 1
Calcinato 1
Calonne-sur-la-Lys 1
Canberra 1
Castegnato 1
Changchun 1
Charlotte 1
Chicago 1
Chiswick 1
Clifton 1
Copenhagen 1
Dietikon 1
Falkenstein 1
Ferrara 1
Frankfurt am Main 1
Guangzhou 1
Gunzenhausen 1
Huntington 1
Krasnoyarsk 1
Totale 4.707
Salva come PNG Salva come JPEG
Nome #
Elevated intraocular pressure in patients with acromegaly 272
High prevalence of radiological vertebral fractures in adult patients with Ehlers-Danlos syndrome 247
Long-term effects of lanreotide SR and octreotide LAR on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly. 148
Growth hormone deficiency in treated acromegaly 135
Effects of somatostatin analogs on glucose homeostasis: a metaanalysis of acromegaly studies. 133
Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study 129
Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors. 124
Development of Graves' hyperthyroidism during the early phase of pregnancy in a patient with pre-existing and long-standing Hashimoto's hypothyroidism. 116
High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial. 116
The long-term cardiovascular outcome of different GH-lowering treatments in acromegaly. 113
Growth hormone receptor polymorphism and the effects of pegvisomant in acromegaly. 111
Bone turnover, bone mineral density, and fracture risk in acromegaly: a meta-analysis 107
MANAGEMENT OF ENDOCRINE DISEASE: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects 107
Glucocorticoids and the regulation of growth hormone secretion. 101
VERTEBRAL FRACTURES IN PATIENTS WITH ACROMEGALY: A 3 - YEAR PROSPECTIVE STUDY 101
Octreotide for acromegaly treatment: a reappraisal. 100
ASSOCIATION BETWEEN L-THYROXINE TREATMENT, GH DEFICIENCY, AND RADIOLOGICAL VERTEBRAL FRACTURES IN PATIENTS WITH ADULT-ONSET HYPOPITUITARISM. 100
Vertebral fractures in males with type 2 diabetes treated with rosiglitazone. 99
Effects of lanreotide SR and Autogel on tumor mass in patients with acromegaly: a systematic review. 98
Cardiovascular risk in aging and obesity: is there a role for GH. 98
Vertebral fractures in males with prolactinoma. 97
Prevalence of vertebral fractures in men with acromegaly 96
Serum TSH values and risk of vertebral fractures in euthyroid post-menopausal women with low bone mineral density. 96
Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma. 96
Biochemical evaluation of patients with active acromegaly and type 2 diabetes mellitus: efficacy and safety of the galanin test. 95
Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women. 95
New understanding and treatments for osteoporosis. 95
Growth hormone deficiency in the adult. 93
Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. 93
Pituitary diseases and bone 91
Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects. 89
Glucocorticoid-induced osteoporosis: clinical and therapeutic aspects. 89
Growth hormone replacement therapy and fracture risk 89
Treatment with metformin is protective against limitations in instrumental activities of daily living in older subjects with type 2 diabetes mellitus. 89
High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment. 89
Active acromegaly enhances spontaneous parathyroid hormone pulsatility. 88
Meta-analysis on the effects of octreotide on tumor mass in acromegaly. 87
Cushing's syndrome and bone. 86
Glucocorticoid-induced osteoporosis: pathophysiology and therapy. 84
Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: A multicenter retrospective study 83
Glucocorticoid-induced osteoporosis: an update. 82
High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas. 82
Effect of gonadal status on bone mineral density and radiological spinal deformities in adult patients with growth hormone deficiency. 81
Growth hormone, insulin like growth factors, and the skeleton 81
Molecular imaging in acromegaly: should clinicians look carefully at developments in the field? 79
Long-term effects of the combination of pegvisomant with somatostatin analogs (SSA) on glucose homeostasis in non-diabetic patients with active acromegaly partially resistant to SSA. 77
Resistance to somatostatin analogs in acromegaly: an evolving concept? 77
Subclinical thyrotoxicosis and bone 76
Commentary:Postsurgical monitoring of acromegaly 73
High Prevalence of Radiological Vertebral Fractures in Women on Thyroid-Stimulating Hormone-Suppressive Therapy for Thyroid Carcinoma 71
GH deficiency in the adult and bone. 66
Drug-induced osteoporosis:mechanism and clinical implications 63
Glucocorticoid-induced osteoporosis and parathyroid hormone. 63
Glucocorticoid replancement therapy and vertebral fractures in hypopituitary adult males with GH deficiency 62
Prevention and treatment of glucocorticoid-induced osteoporosis. 58
Bone Mineral Density and FRAX Score May Not Predict Fracture Risk in Patients With Cancer Undergoing Hormone Deprivation Therapies 57
Diagnosis and treatment of acromegaly and its complications: consensus guidelines. 56
Osteoporosis in HIV patients: an emerging clinical issue 55
Growth Hormone Insuline like Growth Factor-1, and the Kidney Pathophysiological and Clinical Implication 41
Body composition, trabecular bone score and vertebral fractures in subjects with Klinefelter syndrome 40
Long-term effects of lanreotide SR and octreotide LAR on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly. 39
Assessment of DXA derived bone quality indexes and bone geometry parameters in early breast cancer patients: A single center cross-sectional study 33
Real-World Effectiveness of Denosumab and Bisphosphonates on Risk of Vertebral Fractures in Women with Breast Cancer Undergoing Treatment with Aromatase Inhibitors 32
Effect of Degarelix administration on bone health in prostate cancer patients without bone metastases. The Blade study 31
Prediction of vertebral fractures in cancer patients undergoing hormone deprivation therapies: Reliability of who fracture risk assessment tool (frax) and bone mineral density in real-life clinical practice 27
Fat Body Mass and Vertebral Fracture Progression in Women With Breast Cancer 22
Correction: Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors 22
null 13
Bone-active drugs in premenopausal women with breast cancer under hormone-deprivation therapies 10
Heterogeneity in regional changes in body composition induced by androgen deprivation therapy in prostate cancer patients: potential impact on bone health-the BLADE study 9
Prediction of fragility fractures in men with prostate cancer under androgen deprivation therapy: the importance of a multidisciplinary approach using a mini-invasive diagnostic tool 8
Totale 5.961
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.791
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.791
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.112 0 0 0 0 117 175 149 194 144 160 79 94
2020/2021999 16 118 25 107 47 98 56 107 124 123 150 28
2021/2022511 43 105 10 15 5 25 26 32 23 54 39 134
2022/2023401 69 2 2 22 48 119 1 32 66 2 16 22
2023/2024584 28 14 42 54 42 114 26 17 136 6 6 99
2024/2025310 6 3 12 156 133 0 0 0 0 0 0 0
Totale 5.961